Atossa Therapeutics
ATOS
#9381
Rank
NZ$0.15 B
Marketcap
NZ$1.17
Share price
-4.62%
Change (1 day)
-33.78%
Change (1 year)

Market capitalization of Atossa Therapeutics (ATOS)

Market cap: NZ$0.15 Billion

As of December 2025 Atossa Therapeutics has a market cap of NZ$0.15 Billion. This makes Atossa Therapeutics the world's 9381th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Atossa Therapeutics from 2012 to 2025

End of year Market Cap

Year Marketcap Change
2025NZ$0.15 B-30.84%
2024NZ$0.21 B25.51%
2023NZ$0.17 B65.42%
2022NZ$0.10 B-64.46%
2021NZ$0.29 B373.79%
2020NZ$62.6 M194.11%
2019NZ$21.28 M139.42%
2018NZ$8.89 M-24.56%
2017NZ$11.78 M52.84%
2016NZ$7.71 M-49.5%
2015NZ$15.26 M-65.94%
2014NZ$44.83 M-14.51%
2013NZ$52.43 M-14.38%
2012NZ$61.24 M

End of Day market cap according to different sources

On Dec 22nd, 2025 the market cap of Atossa Therapeutics was reported to be:

NZ$0.15 Billion
by Nasdaq info icon info icon
NZ$0.15 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
NZ$849.13 B 560,957.21%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
NZ$36.02 B 23,706.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
NZ$33.53 B 22,055.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
NZ$62.66 M-58.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Translate Bio
TBIO.defunct
NZ$4.83 B 3,095.70%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
NZ$2.75 B 1,718.57%๐Ÿ‡บ๐Ÿ‡ธ USA